U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842601) titled 'Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation' on Sept. 21.

Brief Summary: This study will compare transcranial magnetic stimulation (TMS) with sham TMS in people with opioid use disorder who are taking buprenorphine and have major depressive disorder with ongoing depressive symptoms. The study will evaluate whether TMS improves depressive symptoms and reduces opioid craving. The study will also assess smoking behaviors, treatment acceptability, and any side effects related to TMS.

Study Start Date: Oct. 15

Study Type: INTERVENTIONAL

Condition: Opioid Use Disorder Major Depressive Disorder ...